WORCESTER, MA – Grove Instruments Inc., a medical device company based in Worcester, MA, developing the world’s first noninvasive glucometer today announced that the company has achieved a landmark clinical milestone known internally as “durable calibration.” “This achievement was the last hurdle on the critical path to commercialization of our first product,” explained Arthur Combs, Grove’s CEO. “We have already identified our initial target markets and designed product concepts to address the needs of those markets. Durable Calibration makes them all possible,” continued Combs.
Grove Instruments Inc.
Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there.
The Massachusetts Life Sciences Center awarded a total of $2.2 million in loans to 3 Boston-area life sciences startups – Allurion Technologies, Paragonix Technologies and Intelligent Bio-Systems.
The quasi-public agency’s flagship Accelerator Program provides loans up to $750,000 to early-stage life sciences companies as a part of Massachusetts’ 10 year, $1 billion Life Sciences Initiative.
Nobel prize winner Craig Mello joined the board of directors at Grove Instruments Inc., where he hopes to help make the first non-invasive blood glucose meter a reality.
Mello said he wanted to take a more active role in the Worcester, Mass.-based firm after two years as an advisor.
Boston Scientific Corp. (NYSE:BSX) COO Samuel Leno announced his retirement as executive VP and chief operating officer after three years with med-tech giant.
Leno made the announcement internally on Friday, Oct. 28, according to documents filed with the SEC.
Leno joined Boston Scientific in June 2007 as executive VP of finance and information systems and CFO. In March 2010, he was appointed executive VP and COO.
British health care giant Smith & Nephew (NYSE:SNN) named industry veteran Stéphane Thiroloix as president of its European advanced surgical devices division.
Thiroloix will be based in Baar, Switzerland, and will be responsible for leading and directing all commercial activities in the advanced surgical devices division, specifically the markets focused on orthopedics and sports medicine.
For Immediate Release: October 19, 2011
Contact: Arthur Combs, CEO
Cell: 314 341 3444, email@example.com
MASSDEVICE ON CALL — The Mass. Life Sciences Center, a quasi-public agency that oversees state dollars allocated toward increasing the life sciences industry’s footprint in the Bay State, doled out another $3.8 million in “accelerator” loans.
The program is designed to provide a boost to early-stage life science companies that the center’s scientific advisory board deems to have a high potential for commercialization, rapid growth and the ability to raise substantial capital.